All Articles

Search Article

Bloom, K. (2024) ‘The disparate burden of infectious diseases’, Gene Therapy, pp. 1–3. Available at: https://doi.org/10.1038/s41434-024-00501-w.

Ajoolabady, A. et al. (2024) ‘Inflammation in atherosclerosis: pathophysiology and mechanisms’, Cell Death & Disease, 15(11), pp. 1–16. Available at: https://doi.org/10.1038/s41419-024-07166-8.

Cruz De Casas, P. et al. (2024) ‘Same yet different — how lymph node heterogeneity affects immune responses’, Nature Reviews Immunology, 24(5), pp. 358–374. Available at: https://doi.org/10.1038/s41577-023-00965-8.

Bedi, A. et al. (2024) ‘Rotator cuff tears’, Nature Reviews Disease Primers, 10(1), p. 8. Available at: https://doi.org/10.1038/s41572-024-00492-3.

Zhang, Y. et al. (2024) ‘Roles of long noncoding RNAs in human inflammatory diseases’, Cell Death Discovery, 10(1), p. 235. Available at: https://doi.org/10.1038/s41420-024-02002-6.

Chang, L. et al. (2024) ‘Role of umbilical cord mesenchymal stromal cells in skin rejuvenation’, npj Regenerative Medicine, 9(1), p. 20. Available at: https://doi.org/10.1038/s41536-024-00363-1.

Martinelli, D. et al. (2023) ‘Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations’, Eurosurveillance, 28(43). Available at: https://doi.org/10.2807/1560-7917.ES.2023.28.43.2300131.

Wu, K. et al. (2024) ‘Role of T cells in liver metastasis’, Cell Death & Disease, 15(5), p. 341. Available at: https://doi.org/10.1038/s41419-024-06726-2.

Mukherjee, A.G. et al. (2022) ‘Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach’, Vaccines, 10(9), p. 1493. Available at: https://doi.org/10.3390/vaccines10091493.

Tang, Q. and Khvorova, A. (2024) ‘RNAi-based drug design: considerations and future directions’, Nature Reviews Drug Discovery, 23(5), pp. 341–364. Available at: https://doi.org/10.1038/s41573-024-00912-9.

Seo, Y., Rhim, J. and Kim, J.H. (2024) ‘RNA-binding proteins and exoribonucleases modulating miRNA in cancer: the enemy within’, Experimental & Molecular Medicine, 56(5), pp. 1080–1106. Available at: https://doi.org/10.1038/s12276-024-01224-z.

Liu, W.-W. et al. (2024) ‘RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy’, Signal Transduction and Targeted Therapy, 9(1), p. 70. Available at: https://doi.org/10.1038/s41392-024-01777-5.

Han, D. and Xu, M.M. (no date) ‘RNA Modification in the Immune System’.

Goodall, G.J. and Wickramasinghe, V.O. (2021) ‘RNA in cancer’, Nature Reviews Cancer, 21(1), pp. 22–36. Available at: https://doi.org/10.1038/s41568-020-00306-0.

Kang, J. et al. (2021) ‘Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy’, Signal Transduction and Targeted Therapy, 6(1), p. 323. Available at: https://doi.org/10.1038/s41392-021-00728-8.

Ponne, S. et al. (2024) ‘Reverse engineering protection: A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens’, Vaccine, 42(10), pp. 2503–2518. Available at: https://doi.org/10.1016/j.vaccine.2024.02.087.

Bagnoli, F. et al. (2024) ‘Reverse development of vaccines against antimicrobial-resistant pathogens’, npj Vaccines, 9(1), p. 71. Available at: https://doi.org/10.1038/s41541-024-00858-4.

Suh, J. et al. (2024) ‘Rethinking technology innovation for mental health: framework for multi-sectoral collaboration’, Nature Mental Health, 2(5), pp. 478–488. Available at: https://doi.org/10.1038/s44220-024-00232-2.

Knight, J.S. and Erkan, D. (2024) ‘Rethinking antiphospholipid syndrome to guide future management and research’, Nature Reviews Rheumatology, 20(6), pp. 377–388. Available at: https://doi.org/10.1038/s41584-024-01110-y.

Kassianos, G. et al. (2024) ‘Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines’, Vaccines, 12(1), p. 57. Available at: https://doi.org/10.3390/vaccines12010057.

Garcillán, B. et al. (2022) ‘Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review’, Vaccines, 10(2), p. 297. Available at: https://doi.org/10.3390/vaccines10020297.

Topalidou, X., Kalergis, A.M. and Papazisis, G. (2023) ‘Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines’, Pathogens, 12(10), p. 1259. Available at: https://doi.org/10.3390/pathogens12101259.

Redondo, E. et al. (2024) ‘Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper’, Archivos de Bronconeumología, 60(3), pp. 161–170. Available at: https://doi.org/10.1016/j.arbres.2024.01.004.

Mitsi, E. et al. (2023) ‘Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination’, Nature Communications, 14(1), p. 6815. Available at: https://doi.org/10.1038/s41467-023-42433-w.

Islamuddin, M. and Qin, X. (2024) ‘Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics’, Cell Death Discovery, 10(1), p. 229. Available at: https://doi.org/10.1038/s41420-024-01996-3.

Martyshkina, Y.S. et al. (2023) ‘Reliable Hallmarks and Biomarkers of Senescent Lymphocytes’, International Journal of Molecular Sciences, 24(21), p. 15653. Available at: https://doi.org/10.3390/ijms242115653.

Mertz, P. et al. (2024) ‘Relapsing polychondritis: clinical updates and new differential diagnoses’, Nature Reviews Rheumatology, 20(6), pp. 347–360. Available at: https://doi.org/10.1038/s41584-024-01113-9.

Wang, W. et al. (2023) ‘Regulatory circular RNAs in viral diseases: applications in diagnosis and therapy’, RNA Biology, 20(1), pp. 847–858. Available at: https://doi.org/10.1080/15476286.2023.2272118.

Guan, L. et al. (2023) ‘Regulation of the tumor immune microenvironment by cancer-derived circular RNAs’, Cell Death & Disease, 14(2), p. 132. Available at: https://doi.org/10.1038/s41419-023-05647-w.

Matsuzaka, Y. and Yashiro, R. (2022) ‘Regulation of Extracellular Vesicle-Mediated Immune Responses against Antigen-Specific Presentation’, Vaccines, 10(10), p. 1691. Available at: https://doi.org/10.3390/vaccines10101691.

Chen, Y. et al. (2023) ‘Regulation of CD8+ T memory and exhaustion by the mTOR signals’, Cellular & Molecular Immunology, 20(9), pp. 1023–1039. Available at: https://doi.org/10.1038/s41423-023-01064-3.

Lee, Y.J., Shin, K.J. and Chae, Y.C. (2024) ‘Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer’, Experimental & Molecular Medicine, 56(4), pp. 877–889. Available at: https://doi.org/10.1038/s12276-024-01209-y.

Zelepukin, I.V., Shevchenko, K.G. and Deyev, S.M. (2024) ‘Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery’, Nature Communications, 15(1), p. 4366. Available at: https://doi.org/10.1038/s41467-024-48838-5.

Malapelle, U. et al. (2024) ‘Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer’, British Journal of Cancer [Preprint]. Available at: https://doi.org/10.1038/s41416-024-02709-4.

Kim, M.-Y. et al. (2024) ‘Recombinant immune complexes as vaccines against infectious diseases’, Trends in Biotechnology, p. S0167779924001239. Available at: https://doi.org/10.1016/j.tibtech.2024.05.004.

Li, S. et al. (2023) ‘Recent progress in pneumococcal protein vaccines’, Frontiers in Immunology, 14, p. 1278346. Available at: https://doi.org/10.3389/fimmu.2023.1278346.

Gupta, S. and Pellett, S. (2023) ‘Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines’, Toxins, 15(9), p. 563. Available at: https://doi.org/10.3390/toxins15090563.

Liu, Y. et al. (2024) ‘Recent development of oral vaccines (Review)’, Experimental and Therapeutic Medicine, 27(5), p. 223. Available at: https://doi.org/10.3892/etm.2024.12511.

Wang, E.Y. et al. (2023) ‘Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines’, Biomaterials, 303, p. 122345. Available at: https://doi.org/10.1016/j.biomaterials.2023.122345.

Wang, B. et al. (2023) ‘Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities’, Frontiers in Immunology, 14, p. 1246682. Available at: https://doi.org/10.3389/fimmu.2023.1246682.

Crothers, J.W. and Norton, E.B. (2023) ‘Recent advances in enterotoxin vaccine adjuvants’, Current Opinion in Immunology, 85, p. 102398. Available at: https://doi.org/10.1016/j.coi.2023.102398.

Hargrave, A. et al. (2023) ‘Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines’, Vaccines, 11(11), p. 1633. Available at: https://doi.org/10.3390/vaccines11111633.

Chen, H. et al. (2022) ‘Recent advances in biomedical applications of bacterial outer membrane vesicles’, Journal of Materials Chemistry B, 10(37), pp. 7384–7396. Available at: https://doi.org/10.1039/D2TB00683A.

Nordberg, R.C. et al. (2024) ‘Recent advancements in cartilage tissue engineering innovation and translation’, Nature Reviews Rheumatology, 20(6), pp. 323–346. Available at: https://doi.org/10.1038/s41584-024-01118-4.

Ma, Y. et al. (2024) ‘Rational Design of Lipid-Based Vectors for Advanced Therapeutic Vaccines’, Vaccines, 12(6), p. 603. Available at: https://doi.org/10.3390/vaccines12060603.

Faria, M. et al. (2024) ‘Psychogenic Aging: A Novel Prospect to Integrate Psychobiological Hallmarks of Aging’, Translational Psychiatry, 14(1), p. 226. Available at: https://doi.org/10.1038/s41398-024-02919-7.

Zhang, S. et al. (2024) ‘Protein neddylation and its role in health and diseases’, Signal Transduction and Targeted Therapy, 9(1), p. 85. Available at: https://doi.org/10.1038/s41392-024-01800-9.

Caradonna, T.M. and Schmidt, A.G. (2021) ‘Protein engineering strategies for rational immunogen design’, npj Vaccines, 6(1), p. 154. Available at: https://doi.org/10.1038/s41541-021-00417-1.

Lagousi, T. et al. (2022) ‘Protecting the Offspring, the Gift of Maternal Immunization: Current Status and Future Perspectives’, Vaccines, 10(11), p. 1953. Available at: https://doi.org/10.3390/vaccines10111953.

Reuschenbach, M. et al. (2023) ‘Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer’, Vaccine, 41(42), pp. 6194–6205. Available at: https://doi.org/10.1016/j.vaccine.2023.08.047.